Robert D. Allen
Chief Tech/Sci/R&D Officer chez INVIVYD, INC.
Fortune : - $ au 31/03/2024
Profil
Robert D.
Allen is currently the Chief Scientific Officer at Invivyd, Inc. Prior to this, he held positions as Scientific Director at Oregon Translational Research & Development Institute, Senior Vice President-Research & Development at Sorrento Therapeutics, Inc., and Chief Scientific Officer at SmartPharm Therapeutics, Inc. Allen has a doctorate from The Trustees of Columbia University in The City of New York, a graduate degree from Georgia Institute of Technology, and an undergraduate degree from Rhodes College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 18/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Robert D. Allen
| Sociétés | Poste | Début |
|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 12/04/2023 |
Anciens postes connus de Robert D. Allen
| Sociétés | Poste | Fin |
|---|---|---|
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
| Oregon Translational Research & Development Institute | Chief Tech/Sci/R&D Officer | - |
| SORRENTO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Robert D. Allen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Georgia Institute of Technology | Graduate Degree |
| Rhodes College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Oregon Translational Research & Development Institute | |
SmartPharm Therapeutics, Inc.
SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Health Technology |
